[HTML][HTML] Preclinical interventions in mouse models of frontotemporal dementia due to progranulin mutations
SN Kashyap, NR Boyle, ED Roberson - Neurotherapeutics, 2023 - Elsevier
Heterozygous loss-of-function mutations in progranulin (GRN) cause frontotemporal
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …
[HTML][HTML] Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
SN Kashyap, NR Boyle, ED Roberson - Neurotherapeutics, 2023 - ncbi.nlm.nih.gov
Heterozygous loss-of-function mutations in progranulin (GRN) cause frontotemporal
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations.
SN Kashyap, NR Boyle, ED Roberson - Neurotherapeutics, 2023 - search.ebscohost.com
Heterozygous loss-of-function mutations in progranulin (GRN) cause frontotemporal
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …
[HTML][HTML] Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
SN Kashyap, NR Boyle, ED Roberson - Neurotherapeutics, 2023 - Springer
Heterozygous loss-of-function mutations in progranulin (GRN) cause frontotemporal
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations.
SN Kashyap, NR Boyle, ED Roberson - … : the Journal of the American …, 2023 - europepmc.org
Heterozygous loss-of-function mutations in progranulin (GRN) cause frontotemporal
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …
[HTML][HTML] Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
SN Kashyap, NR Boyle… - …, 2023 - neurotherapeuticsjournal.org
Heterozygous loss-of-function mutations in progranulin (GRN) cause frontotemporal
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
SN Kashyap, NR Boyle… - … : the journal of the …, 2023 - pubmed.ncbi.nlm.nih.gov
Heterozygous loss-of-function mutations in progranulin (GRN) cause frontotemporal
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
SN Kashyap, NR Boyle, ED Roberson - Neurotherapeutics, 2023 - search.proquest.com
Heterozygous loss-of-function mutations in progranulin (GRN) cause frontotemporal
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …
[引用][C] Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
SN Kashyap, NR Boyle, ED Roberson - Neurotherapeutics, 2023 - europepmc.org
Heterozygous loss-of-function mutations in progranulin (GRN) cause frontotemporal
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …
dementia (FTD), a leading cause of early-onset dementia characterized clinically by …